SLSergio Loayza

Sergio Loayza

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sergio Loayza has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Correction: Loayza et al. Monitoring the Performance of National Immunization Programs: Innovative Methodology and Tool for Countries’ Self-Assessment. Vaccines 2026, 14, 258

    by Sergio Loayza, Bertha Capistrán, Marcela Contreras, Martha Velandia, Daniel Salas

    The authors would like to make the following correction to this published paper


  • Open Access

    Monitoring the Performance of National Immunization Programs: Innovative Methodology and Tool for Countries’ Self-Assessment

    by Sergio Loayza, Bertha Capistrán, Marcela Contreras, Martha Velandia, Daniel Salas

    Background/Objectives: In the context of its policy of “Reinvigorating Immunization as a Public Good for Universal Health,” the Pan American Health Organization (PAHO) developed a methodology and tool (MD-PAI) to help Member States of the Americas monitor and assess the performance of their national Expanded Program on Immunization (EPI) for each of the 13 technical components that make up the program. Methods: The MD-PAI was developed in several stages, including review of existing national EPI evaluation methodologies, selection and prioritization of questions for each of the 13 EPI components, piloting of the methodology, final calibration to ensure validity, completeness, reliability, standardization, usefulness, and usability across components and across countries, and publication in the four official languages of the PAHO. Results: The implementation of the MD-PAI enables countries to collect data, document lessons learned, develop action plans to close the most urgent gaps in the short and medium term and enforce the management of the EPI as part of the continuous improvement process. Since its introduction in 2023, fourteen countries in the Americas implemented the MD-PAI, using the results for their short- and medium-term planning and budgeting. Of the 13 components of the EPI, those that have performed best are political priority and planning and programming, while social communication is the component that reported the greatest number of gaps across countries. Conclusions: The PAHO has developed a methodology and tool to help countries to assess their EPIs to identify good practices, gaps and challenges, and develop an action plan to strengthen their programs. However, the impact of vaccination coverages and the epidemiology of vaccine-preventable diseases could take time.


  • Open Access

    End-of-season influenza vaccine effectiveness during the Southern Hemisphere 2022 influenza season – Chile, Paraguay, and Uruguay

    by Anna N. Chard, Francisco Nogareda, Annette K. Regan, María Fernanda Olivares Barraza, Rodrigo A. Fasce, Natalia Vergara, Marcela Avendaño, Elena Penayo, Cynthia Vázquez, Marta Von Horoch, et al.


  • Open Access

    Estimating the burden of influenza‐associated hospitalizations and deaths in Chile during 2012‐2014

    by Viviana Sotomayor, Rodrigo A. Fasce, Natalia Vergara, Felipe De la Fuente, Sergio Loayza, Rakhee Palekar

    Background: Influenza is a vaccine preventable disease that causes important morbidity and mortality worldwide. Estimating the burden of influenza disease is difficult. However, there are some methods based in surveillance data and laboratory testing that can be used for this purpose.Objectives: Estimating the burden of serious illness from influenza by means of hospitalization and death records during the period between 2012 and 2014, and using information from Severe Acute Respiratory Illness (SARI) surveillance.Methods: To estimate the Chilean rate of influenza‐associated hospitalizations and deaths, we applied the influenza positivity of respiratory samples tested in six SARI surveillance sentinel hospitals to the hospitalizations and deaths from the records with ICD‐10 codes from influenza and pneumonia.Results: Annually, 5320 people are hospitalized for influenza and 447 die for this cause. The annual influenza‐associated hospitalization rate for the period was 71.5/100 000 person‐year for <5 years old, 11.8/100 000 person‐year for people between 5 and 64 years old; and 156.0/100 000 person‐year for ≥65 years. The annual mortality rate for the period was 0.08/100 000 person‐year for <5 years; 0.3/100 000 person‐year for people between 5 and 64 years; and 22.8/100 000 person‐year for ≥65 years.Conclusions: This is the first study of influenza burden in Chile. Every year an important quantity of hospitalizations and deaths result from influenza infection. In countries in temperate zones, it is important to know the burden of influenza in order to prepare the health care network and to assess preventive intervention currently in practice and the new ones to implementing.